Solara Active Pharma Sciences Ltd.
| BSE: 541540 | Sector: Health care |
| NSE: SOLARA | ISIN Code: INE624Z01016 |
| BSE 00:00 | 23 May | 413.35 |
-17.05 (-3.96%) |
OPEN
435.55 |
HIGH
435.60 |
LOW
412.40 |
| NSE 00:00 | 23 May | 414.40 |
(%) |
OPEN
430.65 |
HIGH
435.00 |
LOW
412.00 |
| OPEN | 435.55 |
| PREVIOUS CLOSE | 430.40 |
| VOLUME | 7778 |
| 52-Week high | 1842.05 |
| 52-Week low | 400.95 |
| P/E | |
| Mkt Cap.(Rs cr) | 1,488 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Solara Active Pharma Sciences Ltd. (SOLARA) - Announcements
-
Solara Active Pharma Sciences Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance
23/05/2022 | bse |
Downlaod PDF -
Solara Active Pharma Sciences Ltd Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulation
23/05/2022 | bse |
Downlaod PDF -
Solara Active Pharma Sciences Ltd Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulation
21/05/2022 | bse |
Downlaod PDF -
Solara Active Pharma Sciences Ltd Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
13/05/2022 | bse |
Downlaod PDF -
Solara Active Pharma Sciences Ltd Disclosure Of Related Party Transactions For The Period Ended March 31 2022
13/05/2022 | bse |
Downlaod PDF -
Solara Active Pharma Sciences Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
09/05/2022 | bse |
Downlaod PDF -
Solara Active Pharma Sciences Ltd Announcement under Regulation 30 (LODR)-Earnings Call Transcript
06/05/2022 | bse |
Downlaod PDF -
Solara Active Pharma Sciences Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
04/05/2022 | bse |
Downlaod PDF -
Solara Active Pharma Sciences Ltd Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
02/05/2022 | bse |
Downlaod PDF -
Solara Active Pharma Sciences Ltd Announcement under Regulation 30 (LODR)-Investor Presentation
02/05/2022 | bse |
Downlaod PDF -
Solara Active Pharma Sciences Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
30/04/2022 | bse |
Downlaod PDF -
Solara Active Pharma Sciences Ltd Announcement under Regulation 30 (LODR)-Earnings Call Transcript
30/04/2022 | bse |
Downlaod PDF -
Solara Active Pharma Sciences Ltd Announcement under Regulation 30 (LODR)-Change in Directorate
29/04/2022 | bse |
Downlaod PDF -
Solara Active Pharma Sciences Ltd Announcement under Regulation 30 (LODR)-Resignation of Managing Director
29/04/2022 | bse |
Downlaod PDF -
Solara Active Pharma Sciences Ltd Announcement under Regulation 30 (LODR)-Scheme of Arrangement
29/04/2022 | bse |
Downlaod PDF -
Solara Active Pharma Sciences Ltd Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Andyear Ended
29/04/2022 | bse |
Downlaod PDF -
Solara Active Pharma Sciences Ltd Board to consider Dividend
26/04/2022 | bse |
Downlaod PDF -
Solara Active Pharma Sciences Ltd Update on board meeting
26/04/2022 | bse |
Downlaod PDF -
Solara Active Pharma Sciences Ltd Certificate From A Practising Company Secretary Under Regulation 40(9) Of SEBI (Listing Obligations
26/04/2022 | bse |
Downlaod PDF -
Solara Active Pharma Sciences Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
25/04/2022 | bse |
Downlaod PDF
Quick Links for Solara Active Pharma Sciences:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
